查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1952647

多关节上肢復健机器人市场：按产品、技术、最终用户和应用划分－全球预测（2026-2032）

Multi-joint Upper Limb Rehabilitation Robot Market by Product, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，多关节上肢復健机器人市场价值将达到 3.6547 亿美元，到 2026 年将成长至 4.1638 亿美元，到 2032 年将达到 8.7247 亿美元，复合年增长率为 13.23%。

关键市场统计数据
基准年 2025 3.6547亿美元
预计年份：2026年 4.1638亿美元
预测年份 2032 8.7247亿美元
复合年增长率 (%) 13.23%

本文简要概述了影响关节式上肢復健机器人设计选择和应用路径的临床、技术和操作环境。

本执行摘要探讨了关节式上肢復健机器人的发展现状，并概述了设计者、临床医生和投资者所处的技术和临床背景。復健机器人技术已超越概念验证阶段，目前正被应用于医院、门诊復健中心，并越来越多地应用于家庭环境中。驱动机制、感测技术、人机介面和控制演算法的进步，使得相关设备能够支援复杂的多平面上肢运动，并适应患者特定的运动模式。

这是一个重要的技术、临床和交付模式转折点，它将重新定义復健机器人领域的设备设计、治疗范式和系统互通性。

上肢復健机器人领域正经历着由多种因素共同推动的变革。首先，感测器小型化和轻量化致动器的进步催生了新一代穿戴式和可携式系统，拓展了治疗环境。嵌入式运算和边缘人工智慧的进步使得自适应辅助和即时效能回馈无需依赖持续的云端连接即可实现，从而提高了神经復健干预的可靠性并降低了延迟。

2025年前关税变化对復健机器人製造商筹资策略、到岸成本和区域生产决策的影响

影响国际贸易和关税的政策变化正对医疗设备製造商的采购、定价和分销策略产生重大影响。近期实施的关税调整（有效期至2025年）凸显了了解零件、子组件和成品器械累积成本成长的重要性。这些措施促使製造商重新评估供应链，包括供应商多元化、关键生产过程回流以及产品架构的重新设计，以减少对关税敏感型零件的依赖。

详细的細項分析将产品形态、技术方案、最终用户环境以及应用左右差异与商业化和设计优先顺序连结起来。

我们的細項分析揭示了产品、技术、终端用户和应用等各个维度上微妙的需求驱动因素。按产品划分，我们将设备分为固定式和可穿戴式，并着重强调了二者不同的设计重点：固定式平台强调灵活支撑和临床数据采集，而可穿戴式系统则优先考虑便携性、易穿戴性和融入日常生活。按技术划分，我们分析了末端执行器和外骨骼市场，重点阐述了简化控制的特定任务末端执行器解决方案与提供更自然关节辅助和本体感觉反馈的外骨骼架构之间的权衡取舍。

医疗保健系统、报销环境以及重点地区的采用趋势将如何影响产品策略和市场准入

区域趋势正在塑造需求成长的地点、产品的采用方式以及供应商的差异化优势。在美洲，医疗系统采用公私混合采购惯例，并且对能够展现明确临床疗效并可整合到跨专业诊疗路径中的医疗器材表现出浓厚的兴趣。更严格的报销审查和支付方对证据的要求，促使人们更加关注可证实的功能改善和成本效益指标，这正在影响采购週期和培训投入。

从竞争定位的观点，整合临床证据、服务模式、软体生态系统和製造韧性，以确定市场领导地位。

多关节上肢復健机器人领域的竞争格局呈现出多元化的特点，既有成熟的医疗设备製造商，也有专注于机器人Start-Ups，还有以软体主导的新兴参与企业。成熟的医疗设备製造商利用其临床关係和分销网络，拓展可整合到现有医院工作流程中的解决方案；而Start-Ups强调快速的研发週期、创新的控制策略和差异化的用户体验。医疗设备製造商与数位医疗公司之间的策略联盟日益普遍，这反映出将硬体可靠性与软体主导的个人化远端监测相结合的需求。

切实可行的策略挑战，帮助企业提升临床可靠性、供应链韧性、软体整合以及针对特定市场的商业化策略。

产业领导者应推动一系列协作行动，在临床、商业和营运层面创造价值。首先，应优先进行临床检验研究，以证明在实际治疗路径下功能性改善，并设计证据产生方案，以满足医疗负责人者和报销相关人员的需求。来自临床实施点和居家试点计画的补充性真实世界数据（RWE）以及随机对照试验将用于建立全面的结果评估。

我们采用严格的混合方法，结合直接的临床医生对话、观察归纳、文献综合和迭代专家检验，以支持我们的实践发现。

本研究采用质性和量性结合的调查方法，以确保研究结果的可靠性和可重复性。主要研究包括对临床医生、采购专业人员、復健治疗师和设备开发人员进行结构化访谈，以收集有关设备可用性、临床需求和采购限制的第一手资讯。此外，还开展了在临床和家庭环境中对设备实施情况的观察性研究，以评估使用者流程、设定难度和维护注意事项。

对临床证据、产品工程、供应链策略和区域市场推广策略如何协同运作，以确定成功实施和对患者的影响进行综合分析。

总而言之，关节式上肢復健机器人领域正处于一个转折点，技术成熟度、不断变化的医疗服务模式以及政策趋势的交汇，为行业相关人员创造了加速发展的机会和责任。儘管设备的功能日益强大，并能更好地适应不同的医疗环境，但成功的商业化将取决于临床证据、服务模式和区域市场需求之间的清晰契合。到2025年，供应炼和关税压力凸显了製造柔软性和区域策略的必要性，这些策略旨在缩短产品上市时间，提高服务应对力，同时保持利润率。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 多关节上肢復健机器人市场（依产品划分）

  • 固定式
  • 穿戴式装置

9. 依技术分類的多关节上肢復健机器人市场

  • 末端执行器
  • 外骨骼

第十章 多关节上肢復健机器人市场（依最终用户划分）

  • 居家照护
  • 医院
  • 復健中心

第十一章 多关节上肢復健机器人市场（按应用领域划分）

  • 双方
  • 一边
    • 左边
    • 右侧

第十二章 各地区多关节上肢復健机器人市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 多关节上肢復健机器人市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国多关节上肢復健机器人市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 美国多关节上肢復健机器人市场

第十六章 中国多关节上肢復健机器人市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bionik Laboratories Corp.
  • Cyberdyne, Inc.
  • Ekso Bionics Holdings, Inc.
  • Focal Meditech BV
  • Fourier Intelligence Co., Ltd.
  • Hocoma AG
  • Honda Motor Co., Ltd.
  • Kinova Inc.
  • Marsi Bionics
  • Myomo, Inc.
  • Neofect Co., Ltd.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Reha Technology AG
  • ReWalk Robotics Ltd.
  • Steeper Group Ltd.
  • Tyromotion GmbH
  • UBTECH Robotics Corp.
  • Wandercraft SAS
  • Yaskawa Electric Corporation
Product Code: MRR-7A380DA7C554

The Multi-joint Upper Limb Rehabilitation Robot Market was valued at USD 365.47 million in 2025 and is projected to grow to USD 416.38 million in 2026, with a CAGR of 13.23%, reaching USD 872.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 365.47 million
Estimated Year [2026] USD 416.38 million
Forecast Year [2032] USD 872.47 million
CAGR (%) 13.23%

A concise orientation to the clinical, technological, and operational context shaping design choices and adoption pathways for multi-joint upper limb rehabilitation robotics

This executive summary introduces the evolving landscape of multi-joint upper limb rehabilitation robots, framing the technological and clinical context in which designers, clinicians, and investors operate. Rehabilitation robotics has moved beyond proof-of-concept demonstrations to enter deployment phases across hospitals, outpatient rehabilitation centers, and increasingly into the home setting. Improvements in actuation, sensing, human-machine interfaces, and control algorithms have converged to create devices that can support complex, multi-planar upper limb movements while adapting to patient-specific motor profiles.

Clinical evidence has matured, showing improvements in motor function when robotic therapy is combined with task-specific training and high-repetition practice. At the same time, manufacturers are responding to rising demand for devices that are compact, more affordable to operate, and easier for non-specialist caregivers to use. This introduction outlines the key drivers-technological, clinical, and economic-that are reshaping product design and adoption pathways. It also underscores the regulatory and reimbursement environments that influence device commercialization, and sets the stage for subsequent sections which examine market structure, trade policy impacts, regional dynamics, and actionable recommendations for scaling impact.

Major technological, clinical, and delivery-model inflection points that are redefining device design, therapy paradigms, and system interoperability in rehabilitation robotics

The landscape for upper limb rehabilitation robotics is undergoing transformative shifts driven by multiple converging forces. First, miniaturization of sensors and improved lightweight actuators have enabled a new generation of wearable and portable systems that expand the settings in which therapy can take place. Advances in embedded computing and edge AI permit adaptive assistance and real-time performance feedback without reliance on continuous cloud connectivity, increasing reliability and lowering latency for neurorehabilitation interventions.

Second, the therapy paradigm is shifting from therapist-directed, in-clinic sessions toward hybrid models that combine clinic-based intensive training with tele-rehabilitation and supervised home programs. This hybrid approach leverages remote monitoring, progress dashboards, and gamified therapy modules to maintain intensity and adherence outside the clinic. Third, software-driven personalization-rooted in data analytics, motor learning theory, and reinforcement learning-enables systems to adapt challenge levels and assistance profiles dynamically, maximizing neuroplastic gains while reducing risk of over-assistance.

Finally, manufacturing and supply chain innovations, including modular architectures and standardized interfaces, are fostering interoperability and lowering barriers to integration with electronic health records and hospital workflows. Taken together, these shifts create opportunities for new entrants and incumbent firms to redefine value propositions, emphasizing longitudinal outcomes, reduced clinician burden, and measurable cost-efficiencies across care pathways.

How tariff changes through 2025 have reshaped sourcing strategies, landed costs, and regional production decisions for rehabilitation robot manufacturers

Policy shifts affecting international trade and tariffs have materially influenced the sourcing, pricing, and distribution strategies of medical device manufacturers. Recent tariff changes implemented up to 2025 have increased the importance of understanding cumulative cost inflations across components, subassemblies, and finished devices. These measures have catalyzed supply chain re-evaluations, prompting manufacturers to diversify suppliers, onshore critical production steps, and redesign product architectures to reduce dependency on tariff-exposed components.

The cumulative impact of tariff adjustments is manifest in higher landed costs for imported components, which, combined with transportation and regulatory compliance costs, has pressured margins for makers of complex rehabilitation systems. In response, organizations are investing in regional manufacturing hubs, qualifying alternate suppliers in low-tariff jurisdictions, and redesigning bill-of-materials to prioritize locally sourced or tariff-resistant components. Procurement teams are negotiating longer-term contracts and greater price transparency with suppliers to smooth cost volatility.

Moreover, tariff-driven localization has implications for clinical adoption timelines. Devices manufactured closer to end markets tend to benefit from faster certification cycles, more responsive after-sales service, and improved supply continuity-factors that can accelerate hospital procurement decisions. While tariffs add near-term cost complexity, they also incentivize strategic investments in resilient supply chains and manufacturing flexibility that can yield long-term competitive advantage.

Detailed segmentation insights linking product form factor, technological approach, end-user setting, and application laterality to commercialization and design priorities

Segmentation analysis reveals nuanced demand drivers across product, technology, end user, and application dimensions. Based on Product, the market is studied across Stationary and Wearable, highlighting divergent design priorities where stationary platforms emphasize multi-degree-of-freedom support and clinical data capture while wearable systems prioritize portability, ease of donning, and integration into daily routines. Based on Technology, the market is studied across End Effector and Exoskeleton, underscoring the trade-offs between task-specific end-effector solutions that can simplify control and exoskeleton architectures that provide more natural joint-level assistance and proprioceptive feedback.

Based on End User, the market is studied across Home Care, Hospitals, and Rehabilitation Centers, illustrating how procurement cycles, reimbursement frameworks, and clinical workflows vary across settings and shape product feature prioritization. For instance, hospitals and rehabilitation centers typically demand robust data integration, serviceability, and multi-patient scalability, while home care buyers focus on usability, remote monitoring, and cost-effectiveness. Based on Application, the market is studied across Bilateral and Unilateral, with Unilateral further studied across Left and Right, emphasizing how laterality and bilateral coordination tasks influence device kinematics, adaptive algorithms, and therapy protocols.

Taken together, segmentation informs product roadmaps, pricing strategies, and commercialization plans. Developers should align engineering trade-offs with the primary use case and purchaser profile, ensuring that clinical validation pathways correspond to the intended deployment environment. Strategic segmentation also helps prioritize service models, data analytics offerings, and training resources to match the differentiated needs of institutional and consumer-facing channels.

How regional healthcare systems, reimbursement landscapes, and adoption behaviors across major global regions are shaping product strategies and market entry

Regional dynamics are shaping where demand grows, how products are adopted, and which capabilities become differentiators for suppliers. In the Americas, healthcare systems exhibit a mixture of public and private procurement practices with strong interest in devices that demonstrate clear clinical outcomes and that integrate into multidisciplinary care pathways. Reimbursement scrutiny and payer evidence requirements drive a preference for demonstrable functional gains and cost-per-outcome metrics, which influence purchasing timelines and training investments.

In Europe, Middle East & Africa, diverse regulatory regimes and fragmented procurement landscapes create opportunities for regional distributors and localized clinical partnerships. Adoption in this region often correlates with national rehabilitation priorities and the availability of community-based therapy programs, and success frequently depends on tailored service models and training for local clinician groups. In the Asia-Pacific region, rapid digital adoption, an expanding middle-class, and growing investment in home-based care are accelerating interest in both wearable and stationary solutions. Manufacturers that adapt pricing, service networks, and language-localized software stand to capture early growth across a broad spectrum of urban and emerging markets.

Across regions, the common imperative is to align go-to-market strategies with local reimbursement realities, clinician workflows, and patient expectations. Localized clinical evidence generation and strong distribution partnerships remain decisive factors in converting interest into sustained adoption.

An integrated look at competitive positioning combining clinical evidence, service models, software ecosystems, and manufacturing resilience that determines market leadership

Competitive dynamics within the multi-joint upper limb rehabilitation robotics sector are characterized by a mix of established medtech firms, specialized robotics startups, and software-first entrants. Incumbent medical device manufacturers leverage clinical relationships and distribution networks to scale solutions that integrate with existing hospital workflows, while startups emphasize nimble development cycles, innovative control strategies, and differentiated user experiences. Strategic alliances between device makers and digital health companies are increasingly common, reflecting the need to combine hardware reliability with software-driven personalization and remote monitoring.

Investment activity is concentrated on companies that can demonstrate replicable clinical outcomes, scalable manufacturing, and low total cost of ownership for providers. Service and support capabilities are a competitive differentiator, as long-term therapy success hinges on device uptime, training, and data analytics that inform therapy adjustments. Suppliers that offer outcome-tracking dashboards and compliance reporting enhance the value proposition for payers and institutional purchasers. Additionally, partnerships with rehabilitation clinics and academic centers for clinical validation programs remain central to building credibility and informing product iteration.

Given these dynamics, competitive positioning will continue to favor players who can marry rigorous clinical evidence with scalable service models, agile software ecosystems, and resilient supply chains.

Actionable strategic imperatives for companies to strengthen clinical credibility, supply chain resilience, software integration, and market-specific commercialization approaches

Industry leaders should pursue a set of coordinated actions to capture value across clinical, commercial, and operational dimensions. First, prioritize clinical validation studies that demonstrate functional improvements under realistic care pathways, and design evidence generation to satisfy both institutional purchasers and reimbursement stakeholders. Complement randomized or controlled trials with real-world evidence collected from clinical deployments and home-based pilots to build a comprehensive outcomes narrative.

Second, invest in modular design and supply chain flexibility to mitigate tariff and component risks while enabling rapid product customization for diverse end users. This includes qualifying alternate suppliers, standardizing interfaces, and designing for manufacturability. Third, develop integrated software platforms that support adaptive therapy, remote monitoring, and clinician dashboards; such platforms should be architected to enable third-party integrations and to support scalable data analytics that translate usage into actionable clinical insight.

Fourth, tailor go-to-market strategies by region and end-user segment, aligning pricing, service packages, and training programs to the unique needs of hospitals, rehabilitation centers, and home care markets. Finally, foster partnerships with rehabilitation providers, insurers, and research institutions to accelerate adoption, shorten procurement cycles, and co-create reimbursement pathways that recognize long-term functional benefits. Executing on these recommendations will strengthen commercial defensibility and increase the likelihood of meaningful clinical impact.

A rigorous mixed-methods approach combining primary clinician engagement, observational deployments, literature synthesis, and iterative expert validation to underpin actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research involved structured interviews with clinicians, procurement specialists, rehabilitation therapists, and device developers to gather firsthand perspectives on usability, clinical requirements, and procurement constraints. These interviews were complemented by observational studies of device deployments in clinical and home settings to assess user flows, setup burdens, and maintenance considerations.

Secondary research synthesized regulatory guidance, published clinical literature, and technical specifications to map technological trajectories and identify common engineering trade-offs. Data triangulation techniques were applied to reconcile differing data sources and to validate thematic findings. Segmentation analysis utilized product form factor, technological architecture, end-user setting, and application laterality to ensure that device categories and use cases were coherently defined and that implications for design and commercialization were clear.

Throughout the research process, iterative expert review panels provided critical validation of assumptions and helped prioritize areas where additional primary data collection or targeted case studies were necessary. Methodological rigor focused on transparency, reproducibility, and relevance to decision-makers seeking actionable insights for product development and go-to-market planning.

A synthesis of how clinical evidence, product engineering, supply chain strategy, and regional go-to-market execution collectively determine successful deployment and patient impact

In summary, the multi-joint upper limb rehabilitation robotics field stands at an inflection point where technological maturity, shifting care delivery models, and policy dynamics converge to create accelerated opportunities and responsibilities for industry stakeholders. Devices are becoming more capable, adaptable, and suited to diverse care settings, yet commercialization success depends on a clear alignment between clinical evidence, service models, and regional market requirements. Supply chain and tariff pressures through 2025 have highlighted the need for manufacturing flexibility and regional strategies that preserve margins while improving time-to-market and service responsiveness.

Going forward, organizations that integrate rigorous clinical validation with modular engineering, resilient sourcing strategies, and software-enabled remote care will be best positioned to deliver sustained value to patients, providers, and payers. Collaborative partnerships with clinical sites and payers will accelerate adoption, while tailored regional approaches will unlock growth in areas with distinct reimbursement and procurement dynamics. The pathway to impact requires disciplined execution across evidence generation, product design, and commercialization, with a constant focus on measurable functional outcomes and total cost of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Multi-joint Upper Limb Rehabilitation Robot Market, by Product

  • 8.1. Stationary
  • 8.2. Wearable

9. Multi-joint Upper Limb Rehabilitation Robot Market, by Technology

  • 9.1. End Effector
  • 9.2. Exoskeleton

10. Multi-joint Upper Limb Rehabilitation Robot Market, by End User

  • 10.1. Home Care
  • 10.2. Hospitals
  • 10.3. Rehabilitation Centers

11. Multi-joint Upper Limb Rehabilitation Robot Market, by Application

  • 11.1. Bilateral
  • 11.2. Unilateral
    • 11.2.1. Left
    • 11.2.2. Right

12. Multi-joint Upper Limb Rehabilitation Robot Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Multi-joint Upper Limb Rehabilitation Robot Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Multi-joint Upper Limb Rehabilitation Robot Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Multi-joint Upper Limb Rehabilitation Robot Market

16. China Multi-joint Upper Limb Rehabilitation Robot Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bionik Laboratories Corp.
  • 17.6. Cyberdyne, Inc.
  • 17.7. Ekso Bionics Holdings, Inc.
  • 17.8. Focal Meditech BV
  • 17.9. Fourier Intelligence Co., Ltd.
  • 17.10. Hocoma AG
  • 17.11. Honda Motor Co., Ltd.
  • 17.12. Kinova Inc.
  • 17.13. Marsi Bionics
  • 17.14. Myomo, Inc.
  • 17.15. Neofect Co., Ltd.
  • 17.16. Ottobock SE & Co. KGaA
  • 17.17. Parker-Hannifin Corporation
  • 17.18. Reha Technology AG
  • 17.19. ReWalk Robotics Ltd.
  • 17.20. Steeper Group Ltd.
  • 17.21. Tyromotion GmbH
  • 17.22. UBTECH Robotics Corp.
  • 17.23. Wandercraft SAS
  • 17.24. Yaskawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END EFFECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY LEFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY RIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 98. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GCC MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. G7 MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NATO MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA MULTI-JOINT UPPER LIMB REHABILITATION ROBOT MARKET SIZE, BY UNILATERAL, 2018-2032 (USD MILLION)